Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. H. Lundbeck A/S
  6. News
  7. Summary
    LUN   DK0010287234

H. LUNDBECK A/S

(LUN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

H Lundbeck A/S : Lundbeck, Otsuka to Push Through With Recruitment in Late-Stage Study of Dementia Drug

04/13/2021 | 02:42am EDT


ę MT Newswires 2021
All news about H. LUNDBECK A/S
06/15#1VOICESUMMIT : Partnering with the advocacy community to further brain health a..
PU
06/11H LUNDBECK A/Sá : Lundbeck CEO, Deborah Dunsire, warns that we could be on the b..
PU
05/31H LUNDBECK A/Sá : Interpretation Of The Term "export" In The Indian Patent Conte..
AQ
05/26H LUNDBECK A/Sá : Transactions with shares and linked securities in H. Lundbeck ..
AQ
05/24H LUNDBECK A/Sá : The Hunt for a New Weapon Against Schizophrenia
PU
05/11H LUNDBECK A/Sá : Lundbeck delivers a solid EBIT of DKK 882 million and Vyepti i..
AQ
05/03H LUNDBECK A/Sá : Lundbeck - New study finds that vortioxetine helps patients wi..
AQ
05/03H LUNDBECK A/Sá : Lundbeck Drug Improves Symptoms in People With Major Depressiv..
MT
05/03H LUNDBECK A/Sá : New study finds that vortioxetine helps patients with MDD and ..
AQ
04/22H LUNDBECK A/Sá : Vortioxetine significantly improves overall functioning in a g..
AQ
More news
Financials
Sales 2021 16 640 M 2 656 M 2 656 M
Net income 2021 1 484 M 237 M 237 M
Net Debt 2021 2 283 M 364 M 364 M
P/E ratio 2021 26,3x
Yield 2021 1,44%
Capitalization 38 518 M 6 141 M 6 147 M
EV / Sales 2021 2,45x
EV / Sales 2022 2,17x
Nbr of Employees 5 551
Free-Float 30,7%
Chart H. LUNDBECK A/S
Duration : Period :
H. Lundbeck A/S Technical Analysis Chart | LUN | DK0010287234 | MarketScreener
Technical analysis trends H. LUNDBECK A/S
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 246,00 DKK
Last Close Price 193,85 DKK
Spread / Highest target 54,8%
Spread / Average Target 26,9%
Spread / Lowest Target -5,60%
EPS Revisions
Managers and Directors
NameTitle
Deborah L. Dunsire President & Chief Executive Officer
Anders G÷tzsche Chief Financial Officer & Executive Vice President
Lars S°ren Rasmussen Chairman
Lars Bang Executive VP-Supply Operations & Engineering
Johan Luthman EVP & Head-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
H. LUNDBECK A/S-7.16%6 141
JOHNSON & JOHNSON2.92%426 557
ROCHE HOLDING AG12.70%325 803
PFIZER, INC.5.43%217 246
NOVARTIS AG2.47%208 642
ABBVIE INC.5.57%199 795